SITC Announces Special Anniversary Lifetime Achievement Award; Names Longtime Society Executive Director, Tara Withington, CAE, as Inaugural Recipient
The Society for Immunotherapy of Cancer (SITC) is pleased to announce Tara Withington, CAE, the society's longtime executive director, as the inaugural recipient of a special anniversary Lifetime Achievement Award. To permanently honor her legacy, SITC also announces with great enthusiasm the official renaming of the Public Service Award to the Tara Withington Public Service Award.
MILWAUKEE, Nov. 13, 2020 /PRNewswire-PRWeb/ -- The Society for Immunotherapy of Cancer (SITC) is pleased to announce Tara Withington, CAE, the society's longtime executive director, as the inaugural recipient of a special anniversary Lifetime Achievement Award. To permanently honor her legacy, SITC also announces with great enthusiasm the official renaming of the Public Service Award to the Tara Withington Public Service Award.
With over 20 years of service as SITC's executive director, Withington has critically expanded the impact of the society beyond the scientific and clinical community to government, regulatory agencies, industry and, most importantly, patients. Implementing the vision of dozens of leaders' year-after-year, her leadership created SITC as an integrated community of genuine thought leaders, in both challenging and prosperous times.
"Tara represents the heart of SITC and of our cancer immunotherapy community," said SITC President Mario Sznol, MD. "She molded the society with heart, a warm spirit, and, in the early days, grit."
Withington is the visionary behind many of the society's marquee initiatives and programs including, but not limited to, SITC's connectED platform; Sparkathon program; the Certificate in Cancer Immunotherapy, Advances in Cancer Immunotherapy™ regional education program and the Primer as part of the society's Annual Meeting offering.
Anniversary Awards are presented every five years and celebrate the extraordinary achievements of leaders in the cancer immunotherapy and tumor immunology field. It is without question that SITC celebrates 35 years of harnessing the immune system to transform cancer outcomes because of the tireless work put forth by many young investigators, luminaries, leading organizations, regulatory agencies and companies propel the field forward and build a solid foundation for future advances and soon, a cure.
The society's 35th Anniversary Annual Meeting (SITC 2020) concludes on Saturday, Nov. 14, 2020. Click here to register for access to all on-demand content, available on the virtual event platform through Dec. 31, 2020.
About SITC
Established in 1984, the Society for Immunotherapy of Cancer (SITC) is a nonprofit organization of medical professionals dedicated to improving cancer patient outcomes by advancing the development, science and application of cancer immunotherapy and tumor immunology. SITC is comprised of influential basic and translational scientists, practitioners, health care professionals, government leaders and industry professionals around the globe. Through educational initiatives that foster scientific exchange and collaboration among leaders in the field, SITC aims to one day make the word "cure" a reality for cancer patients everywhere. Learn more about SITC, our educational offerings and other resources at sitcancer.org and follow us on Twitter, LinkedIn, Facebook and YouTube.
Media Contact
Laura Burns, Society for Immunotherapy of Cancer, (414) 271-2456, [email protected]
SOURCE Society for Immunotherapy of Cancer
Share this article